Market Cap 2.50B
Revenue (ttm) 874.84M
Net Income (ttm) 263.86M
EPS (ttm) N/A
PE Ratio 7.42
Forward PE N/A
Profit Margin 30.16%
Debt to Equity Ratio -1.55
Volume 4,860,000
Avg Vol 5,090,894
Day's Range N/A - N/A
Shares Out 254.16M
Stochastic %K 46%
Beta 0.55
Analysts Strong Sell
Price Target $21.50

Company Profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat HAE. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 919 859 1302
Fax: 919 859 1314
Address:
4505 Emperor Boulevard, Suite 200, Durham, United States
Paulzk
Paulzk Jul. 4 at 7:36 PM
$BCRX Astria Therapeutics 2026 Company Corporate Office 22 Boston Wharf Road 10th Floor Boston, MA 02210 Astria Therapeutics, Inc. has an estimated 78 employees. The Boston, Massachusetts-based biopharmaceutical company has steadily grown its headcount over recent years, scaling from about 29 employees in 2021 to support its expanding clinical development programs
0 · Reply
Paulzk
Paulzk Jul. 4 at 7:25 PM
$BCRX Until 2026 it maintained a 35,000 square-foot "Discovery Research Center and Laboratory Center of Excellence" (or "Discovery Center of Excellence") with approximately 60 employees at 2100 Riverchase Center in Riverchase Corporate Park, Building 200, Suite 200. City, 35244 Birmingham, AL.. The center was headed by chief discovery officer Yarlagadda Babu.
0 · Reply
Jccjax
Jccjax Jul. 4 at 3:28 PM
$BCRX been here since 2021, held through the $20 price surge, and have basically been treading water since then trying to convince myself to hold out until I can at least get a inoffensive return on my investment for five years of parked money. Everyone is beating the buyout drum here based on the recent PR, but I’m not seeing any indication from CG‘s comments that this was a move with that objective in mind. Hoping we get a solid price bump off of this pivot so I can finally exit and move on with my life. There’s no buyout coming.
2 · Reply
Bfunk17
Bfunk17 Jul. 3 at 11:14 PM
$BCRX The Alabama employees are already posting "Available to Work." I found numerous.
0 · Reply
2YrsEarly
2YrsEarly Jul. 3 at 4:32 PM
$BCRX Enjoy the weekend everyone!
0 · Reply
Breton2018
Breton2018 Jul. 3 at 11:21 AM
0 · Reply
Paulzk
Paulzk Jul. 3 at 3:47 AM
$BCRX Independence Day Friday, July 3, 2026 Market Closed
0 · Reply
Agent205
Agent205 Jul. 3 at 3:39 AM
$BCRX Happy 4th of Julie you beautiful people!!! HOLD this Mf'er like there's no tomorrow (cuz there aren't many left). 😂 $BCRX primed and glammed for the runway......
1 · Reply
Paulzk
Paulzk Jul. 3 at 3:23 AM
$BCRX Pfizer's CEO Says His Company Has a "Very Big Balance Sheet" to Do Deals. Here's the Perfect Next Acquisition Target for the Pharma Giant. https://finance.yahoo.com/healthcare/articles/pfizers-ceo-says-company-very-212000322.html
0 · Reply
Paulzk
Paulzk Jul. 3 at 3:20 AM
$BCRX Drones for crowd control in our future there goes the right to protest and assemble! Looking for a way to stop a threat without taking a life, Rick teamed up with Jack Cover, the original Taser inventor and former NASA researcher, to redesign his 1970s-era weapon concept. It's like the book 1984 https://finance.yahoo.com/markets/article/ceo-of-taser-maker-axon-drones-that-stun-perpetrators-are-in-our-future-132334656.html
1 · Reply
Latest News on BCRX
BioCryst to present new Orladeyo data at EAACI

2026-06-12T11:15:09.000Z - 22 days ago

BioCryst to present new Orladeyo data at EAACI


BioCryst price target raised to $28 from $25 at Citizens

2026-05-07T11:43:06.000Z - 2 months ago

BioCryst price target raised to $28 from $25 at Citizens


BioCryst reports Q1 EPS ($2.98), consensus 11c

2026-05-07T06:49:24.000Z - 2 months ago

BioCryst reports Q1 EPS ($2.98), consensus 11c


BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2026


BioCryst Pharmaceuticals Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

BioCryst Pharmaceuticals Earnings release: Q1 2026


BioCryst Pharmaceuticals Slides: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

BioCryst Pharmaceuticals Slides: Q1 2026


BioCryst Pharmaceuticals Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

BioCryst Pharmaceuticals Quarterly report: Q1 2026


BioCryst to Present at Upcoming Investor Conferences

Apr 28, 2026, 7:00 AM EDT - 2 months ago

BioCryst to Present at Upcoming Investor Conferences


BioCryst Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

BioCryst Pharmaceuticals Proxy statement: Proxy filing


BioCryst Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

BioCryst Pharmaceuticals Proxy statement: Proxy filing


BioCryst to Report First Quarter 2026 Financial Results on May 6

Apr 15, 2026, 7:00 AM EDT - 2 months ago

BioCryst to Report First Quarter 2026 Financial Results on May 6


BioCryst price target raised to $14 from $13 at RBC Capital

2026-04-07T15:13:58.000Z - 3 months ago

BioCryst price target raised to $14 from $13 at RBC Capital


BioCryst reports inducement grants under Nasdaq listing rule

2026-03-04T12:08:31.000Z - 4 months ago

BioCryst reports inducement grants under Nasdaq listing rule


BioCryst price target raised to $22 from $21 at Wedbush

2026-03-02T13:53:06.000Z - 4 months ago

BioCryst price target raised to $22 from $21 at Wedbush


BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025


BioCryst Pharmaceuticals Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

BioCryst Pharmaceuticals Annual report: Q4 2025


BioCryst Pharmaceuticals Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

BioCryst Pharmaceuticals Earnings release: Q4 2025


BioCryst Pharmaceuticals Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

BioCryst Pharmaceuticals Slides: Q4 2025


BioCryst reports Q4 EPS $1.12 vs (13c) last year

2026-02-26T12:19:23.000Z - 4 months ago

BioCryst reports Q4 EPS $1.12 vs (13c) last year


BioCryst resumed with an Outperform at Evercore ISI

2026-02-18T13:16:21.000Z - 4 months ago

BioCryst resumed with an Outperform at Evercore ISI


BioCryst to Present at Upcoming Investor Conference

Feb 17, 2026, 7:00 AM EST - 4 months ago

BioCryst to Present at Upcoming Investor Conference


BioCryst completes acquisition of Astria Therapeutics

2026-01-23T14:05:15.000Z - 5 months ago

BioCryst completes acquisition of Astria Therapeutics

ATXS


BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2025


BioCryst Pharmaceuticals Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

BioCryst Pharmaceuticals Quarterly report: Q3 2025


BioCryst Pharmaceuticals Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

BioCryst Pharmaceuticals Earnings release: Q3 2025


BioCryst Pharmaceuticals Slides: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

BioCryst Pharmaceuticals Slides: Q3 2025


BioCryst Pharmaceuticals Transcript: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 9 months ago

BioCryst Pharmaceuticals Transcript: M&A Announcement


BioCryst Pharmaceuticals Press release: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 9 months ago

BioCryst Pharmaceuticals Press release: M&A Announcement


BioCryst Pharmaceuticals Slides: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 9 months ago

BioCryst Pharmaceuticals Slides: M&A Announcement


BioCryst to buy Astria Therapeutics in $700 million deal

Oct 14, 2025, 7:35 AM EDT - 9 months ago

BioCryst to buy Astria Therapeutics in $700 million deal

ATXS


BioCryst Announces Departure of Dr. Helen Thackray

Aug 11, 2025, 7:00 AM EDT - 11 months ago

BioCryst Announces Departure of Dr. Helen Thackray


BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 11 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2025


BioCryst Pharmaceuticals Quarterly report: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 11 months ago

BioCryst Pharmaceuticals Quarterly report: Q2 2025


BioCryst Pharmaceuticals Earnings release: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 11 months ago

BioCryst Pharmaceuticals Earnings release: Q2 2025


BioCryst Pharmaceuticals Slides: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 11 months ago

BioCryst Pharmaceuticals Slides: Q2 2025


BioCryst Pharmaceuticals Transcript: M&A Announcement

Jun 27, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Transcript: M&A Announcement


BioCryst Pharmaceuticals Press release: M&A Announcement

Jun 27, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Press release: M&A Announcement


ORLADEYO® (berotralstat) Approved in Colombia

Jun 13, 2025, 7:00 AM EDT - 1 year ago

ORLADEYO® (berotralstat) Approved in Colombia


BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2025


BioCryst Pharmaceuticals Quarterly report: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Quarterly report: Q1 2025


BioCryst Pharmaceuticals Earnings release: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q1 2025


BioCryst Pharmaceuticals Slides: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Slides: Q1 2025


BioCryst Appoints Steve Frank to Board of Directors

May 1, 2025, 7:00 AM EDT - 1 year ago

BioCryst Appoints Steve Frank to Board of Directors


BioCryst Pharmaceuticals Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

BioCryst Pharmaceuticals Proxy statement: Proxy Filing


BioCryst Pharmaceuticals Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

BioCryst Pharmaceuticals Proxy statement: Proxy Filing


BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2024

Feb 24, 2025, 8:30 AM EST - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2024


BioCryst Pharmaceuticals Annual report: Q4 2024

Feb 24, 2025, 8:30 AM EST - 1 year ago

BioCryst Pharmaceuticals Annual report: Q4 2024


BioCryst Pharmaceuticals Earnings release: Q4 2024

Feb 24, 2025, 8:30 AM EST - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q4 2024


BioCryst Pharmaceuticals Slides: Q4 2024

Feb 24, 2025, 8:30 AM EST - 1 year ago

BioCryst Pharmaceuticals Slides: Q4 2024


BioCryst Launches ORLADEYO® (berotralstat) in Portugal

Feb 12, 2025, 7:00 AM EST - 1 year ago

BioCryst Launches ORLADEYO® (berotralstat) in Portugal


Paulzk
Paulzk Jul. 4 at 7:36 PM
$BCRX Astria Therapeutics 2026 Company Corporate Office 22 Boston Wharf Road 10th Floor Boston, MA 02210 Astria Therapeutics, Inc. has an estimated 78 employees. The Boston, Massachusetts-based biopharmaceutical company has steadily grown its headcount over recent years, scaling from about 29 employees in 2021 to support its expanding clinical development programs
0 · Reply
Paulzk
Paulzk Jul. 4 at 7:25 PM
$BCRX Until 2026 it maintained a 35,000 square-foot "Discovery Research Center and Laboratory Center of Excellence" (or "Discovery Center of Excellence") with approximately 60 employees at 2100 Riverchase Center in Riverchase Corporate Park, Building 200, Suite 200. City, 35244 Birmingham, AL.. The center was headed by chief discovery officer Yarlagadda Babu.
0 · Reply
Jccjax
Jccjax Jul. 4 at 3:28 PM
$BCRX been here since 2021, held through the $20 price surge, and have basically been treading water since then trying to convince myself to hold out until I can at least get a inoffensive return on my investment for five years of parked money. Everyone is beating the buyout drum here based on the recent PR, but I’m not seeing any indication from CG‘s comments that this was a move with that objective in mind. Hoping we get a solid price bump off of this pivot so I can finally exit and move on with my life. There’s no buyout coming.
2 · Reply
Bfunk17
Bfunk17 Jul. 3 at 11:14 PM
$BCRX The Alabama employees are already posting "Available to Work." I found numerous.
0 · Reply
2YrsEarly
2YrsEarly Jul. 3 at 4:32 PM
$BCRX Enjoy the weekend everyone!
0 · Reply
Breton2018
Breton2018 Jul. 3 at 11:21 AM
0 · Reply
Paulzk
Paulzk Jul. 3 at 3:47 AM
$BCRX Independence Day Friday, July 3, 2026 Market Closed
0 · Reply
Agent205
Agent205 Jul. 3 at 3:39 AM
$BCRX Happy 4th of Julie you beautiful people!!! HOLD this Mf'er like there's no tomorrow (cuz there aren't many left). 😂 $BCRX primed and glammed for the runway......
1 · Reply
Paulzk
Paulzk Jul. 3 at 3:23 AM
$BCRX Pfizer's CEO Says His Company Has a "Very Big Balance Sheet" to Do Deals. Here's the Perfect Next Acquisition Target for the Pharma Giant. https://finance.yahoo.com/healthcare/articles/pfizers-ceo-says-company-very-212000322.html
0 · Reply
Paulzk
Paulzk Jul. 3 at 3:20 AM
$BCRX Drones for crowd control in our future there goes the right to protest and assemble! Looking for a way to stop a threat without taking a life, Rick teamed up with Jack Cover, the original Taser inventor and former NASA researcher, to redesign his 1970s-era weapon concept. It's like the book 1984 https://finance.yahoo.com/markets/article/ceo-of-taser-maker-axon-drones-that-stun-perpetrators-are-in-our-future-132334656.html
1 · Reply
Paulzk
Paulzk Jul. 3 at 3:09 AM
$BCRX Long-term unemployment — the measure of those who have been out of work at least 27 weeks as a share of the total number of jobless people — dipped a tad in June but is holding above 27%. Outside of the COVID-19 pandemic and recovery, long-term unemployment hasn't been that high since 2016. Last month, 1.9 million people had been out of work for almost seven months or longer — 286,000 more than a year ago. Meanwhile, the labor force participation rate, or the share of the population who are working or have actively sought employment, slid to 61.5%, the lowest since March 2021. https://finance.yahoo.com/economy/article/unemployment-dipped-but-more-people-left-the-workforce-whats-going-on-in-the-job-market-185543008.html
0 · Reply
Paulzk
Paulzk Jul. 3 at 2:56 AM
$BCRX Picking a winner in the Alzheimers drug development is tough, many to choose from. Small company list. https://biotech-careers.org/business-area/alzheimers
0 · Reply
Paulzk
Paulzk Jul. 3 at 2:26 AM
$BCRX In 2025, polling firm Gallup said that just 54 percent of Americans drink alcohol -- the lowest number since it began asking the question in 1939. By contrast, market research firm Euromonitor says sales of cannabis beverages are exploding as more products migrate from niche stores to mainstream shops. https://finance.yahoo.com/small-business/articles/cracking-open-cannabis-americas-pastime-012736440.html
2 · Reply
LatinPimp
LatinPimp Jul. 3 at 2:18 AM
$BCRX like if buyout this year
3 · Reply
Paulzk
Paulzk Jul. 2 at 9:21 PM
$BCRX Biocryst PharmaceuticalsExtended hours price per share$9.84 $0.00 (0.00%) Bid ARCX 9.63 x 2000 Ask MEMX 9.84 x 200 Volume 4,859,295
0 · Reply
SCCT2FL
SCCT2FL Jul. 2 at 9:04 PM
$TGTX and back from down $2.20 a share $BCRX was down 13 cents a share and down after a few great days and came back green $AUPH was down 57 cents a share and is now down 3 cents on the day. Seems like a lot of games being played in bio recently. All 3 are BO candidates (subject to who you ask) and these games at the end are made to shake people out so the big boys can get in cheaper. Not saying that's what's happening to all 3 because they've all been manipulated for years, but the recent action in all is odd
2 · Reply
SCCT2FL
SCCT2FL Jul. 2 at 8:44 PM
$BCRX is there any AH volume at all? ST is saying we're stuck at the closing price.
1 · Reply
Fergus20
Fergus20 Jul. 2 at 8:42 PM
$BCRX pride flag
0 · Reply
Fergus20
Fergus20 Jul. 2 at 8:18 PM
$BCRX bull flag.
0 · Reply
Money_Mane
Money_Mane Jul. 2 at 8:09 PM
$BCRX wish we were over 10 but nice close
1 · Reply
Iwillbuy
Iwillbuy Jul. 2 at 8:04 PM
$BCRX no buy out my arse…! Big buys
1 · Reply
Paulzk
Paulzk Jul. 2 at 8:04 PM
$BCRX Impressive comeback
0 · Reply